These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 29261177)

  • 1. Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome, and spinal muscular atrophy in Australia: outcomes of 12,000 tests.
    Archibald AD; Smith MJ; Burgess T; Scarff KL; Elliott J; Hunt CE; McDonald Z; Barns-Jenkins C; Holt C; Sandoval K; Siva Kumar V; Ward L; Allen EC; Collis SV; Cowie S; Francis D; Delatycki MB; Yiu EM; Massie RJ; Pertile MD; du Sart D; Bruno D; Amor DJ
    Genet Med; 2018 Apr; 20(5):513-523. PubMed ID: 29261177
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Carrier Screening Programs for Cystic Fibrosis, Fragile X Syndrome, Hemoglobinopathies and Thalassemia, and Spinal Muscular Atrophy: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2023; 23(4):1-398. PubMed ID: 37637488
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population genomic screening of all young adults in a health-care system: a cost-effectiveness analysis.
    Zhang L; Bao Y; Riaz M; Tiller J; Liew D; Zhuang X; Amor DJ; Huq A; Petelin L; Nelson M; James PA; Winship I; McNeil JJ; Lacaze P
    Genet Med; 2019 Sep; 21(9):1958-1968. PubMed ID: 30773532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reproductive genetic carrier screening for cystic fibrosis, fragile X syndrome and spinal muscular atrophy: patterns of community and healthcare provider participation in a Victorian screening program.
    Leibowitz R; Lewis S; Emery J; Massie J; Smith M; Delatycki M; Archibald A
    Aust J Prim Health; 2022 Dec; 28(6):580-587. PubMed ID: 36192111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Making a (cautious) case for expanding reproductive genetic carrier screens: Australian researchers report success, and caveats, with a simultaneous panel of cystic fibrosis, fragile X syndrome, and spinal muscular atrophy.
    Am J Med Genet A; 2018 Mar; 176(3):510-512. PubMed ID: 29446568
    [No Abstract]   [Full Text] [Related]  

  • 6. "I'm Healthy, It's Not Going To Be Me": Exploring experiences of carriers identified through a population reproductive genetic carrier screening panel in Australia.
    Beard CA; Amor DJ; Di Pietro L; Archibald AD
    Am J Med Genet A; 2016 Aug; 170(8):2052-9. PubMed ID: 27150953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Carrier Screening and Prenatal Diagnosis for Spinal Muscular Atrophy in 13,069 Chinese Pregnant Women.
    Zhang J; Wang Y; Ma D; Sun Y; Li Y; Yang P; Luo C; Jiang T; Hu P; Xu Z
    J Mol Diagn; 2020 Jun; 22(6):817-822. PubMed ID: 32205292
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic fibrosis carrier population screening in the primary care setting.
    Loader S; Caldwell P; Kozyra A; Levenkron JC; Boehm CD; Kazazian HH; Rowley PT
    Am J Hum Genet; 1996 Jul; 59(1):234-47. PubMed ID: 8659530
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Socioeconomic status and uptake of reproductive carrier screening in Australia.
    Robson SJ; Caramins M; Saad M; Suthers G
    Aust N Z J Obstet Gynaecol; 2020 Dec; 60(6):976-979. PubMed ID: 32748403
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Carrier screening for spinal muscular atrophy (SMA) in 107,611 pregnant women during the period 2005-2009: a prospective population-based cohort study.
    Su YN; Hung CC; Lin SY; Chen FY; Chern JP; Tsai C; Chang TS; Yang CC; Li H; Ho HN; Lee CN
    PLoS One; 2011 Feb; 6(2):e17067. PubMed ID: 21364876
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanded carrier screening in gamete donors of Venezuela.
    Urbina MT; Benjamin I; Medina R; Jiménez J; Trías L; Lerner J
    JBRA Assist Reprod; 2017 Dec; 21(4):356-360. PubMed ID: 29099150
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Joint SOGC-CCMG Opinion for Reproductive Genetic Carrier Screening: An Update for All Canadian Providers of Maternity and Reproductive Healthcare in the Era of Direct-to-Consumer Testing.
    Wilson RD; De Bie I; Armour CM; Brown RN; Campagnolo C; Carroll JC; Okun N; Nelson T; Zwingerman R; Audibert F; Brock JA; Brown RN; Campagnolo C; Carroll JC; De Bie I; Johnson JA; Okun N; Pastruck M; Vallée-Pouliot K; Wilson RD; Zwingerman R; Armour C; Chitayat D; De Bie I; Fernandez S; Kim R; Lavoie J; Leonard N; Nelson T; Taylor S; Van Allen M; Van Karnebeek C
    J Obstet Gynaecol Can; 2016 Aug; 38(8):742-762.e3. PubMed ID: 27638987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Circulating trophoblastic cells provide genetic diagnosis in 63 fetuses at risk for cystic fibrosis or spinal muscular atrophy.
    Mouawia H; Saker A; Jais JP; Benachi A; Bussières L; Lacour B; Bonnefont JP; Frydman R; Simpson JL; Paterlini-Brechot P
    Reprod Biomed Online; 2012 Nov; 25(5):508-20. PubMed ID: 23000084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pan-ethnic carrier screening and prenatal diagnosis for spinal muscular atrophy: clinical laboratory analysis of >72,400 specimens.
    Sugarman EA; Nagan N; Zhu H; Akmaev VR; Zhou Z; Rohlfs EM; Flynn K; Hendrickson BC; Scholl T; Sirko-Osadsa DA; Allitto BA
    Eur J Hum Genet; 2012 Jan; 20(1):27-32. PubMed ID: 21811307
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preconception or prenatal acceptance of SMN1 gene carrier screening and carrier rate of spinal muscular atrophy: a retrospective study in 18,818 reproductive age women in Wuhan area of China.
    Sun Y; Ma S; Xiao J; Wu J; Wu Y; Shi X; Li S; Feng L; Chen S
    J Assist Reprod Genet; 2024 Jan; 41(1):127-133. PubMed ID: 37991656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of a cystic fibrosis carrier testing clinic for couples.
    Christie LM; Ingrey AJ; Turner GM; Proos AL; Watts GE
    Med J Aust; 2009 Nov; 191(9):499-501. PubMed ID: 19883345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Compliance for genetic screening in the Arab population in Israel.
    Sukenik-Halevy R; Leil-Zoabi UA; Peled-Perez L; Zlotogora J; Allon-Shalev S
    Isr Med Assoc J; 2012 Sep; 14(9):538-42. PubMed ID: 23101415
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Population screening for reproductive risk for single gene disorders in Australia: now and the future.
    Delatycki MB
    Twin Res Hum Genet; 2008 Aug; 11(4):422-30. PubMed ID: 18637742
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genetic counseling and carrier screening in candidates for gamete donation at a Portuguese center.
    Soares CA; Tkachenko N; Vale-Fernandes E; Barreiro M; Abreu M; Reis CF; Soares G; Fortuna AM; Soares AR
    JBRA Assist Reprod; 2023 Jun; 27(2):180-184. PubMed ID: 35916466
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of a national population-based carrier-screening program on spinal muscular atrophy births.
    Aharoni S; Nevo Y; Orenstein N; Basel-Salmon L; Ben-Shachar S; Mussaffi H; Sagi-Dain L; Cohen R; Singer A
    Neuromuscul Disord; 2020 Dec; 30(12):970-974. PubMed ID: 33218846
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.